Literature DB >> 22970276

The sortase A substrates FnbpA, FnbpB, ClfA and ClfB antagonize colony spreading of Staphylococcus aureus.

Eleni Tsompanidou1, Emma L Denham, Mark J J B Sibbald, Xiao-Mei Yang, Jolien Seinen, Alexander W Friedrich, Girbe Buist, Jan Maarten van Dijl.   

Abstract

Staphylococcus aureus is an important human pathogen that is renowned both for its rapid transmission within hospitals and the community, and for the formation of antibiotic resistant biofilms on medical implants. Recently, it was shown that S. aureus is able to spread over wet surfaces. This motility phenomenon is promoted by the surfactant properties of secreted phenol-soluble modulins (PSMs), which are also known to inhibit biofilm formation. The aim of the present studies was to determine whether any cell surface-associated S. aureus proteins have an impact on colony spreading. To this end, we analyzed the spreading capabilities of strains lacking non-essential components of the protein export and sorting machinery. Interestingly, our analyses reveal that the absence of sortase A (SrtA) causes a hyper-spreading phenotype. SrtA is responsible for covalent anchoring of various proteins to the staphylococcal cell wall. Accordingly, we show that the hyper-spreading phenotype of srtA mutant cells is an indirect effect that relates to the sortase substrates FnbpA, FnbpB, ClfA and ClfB. These surface-exposed staphylococcal proteins are known to promote biofilm formation, and cell-cell interactions. The hyper-spreading phenotype of srtA mutant staphylococcal cells was subsequently validated in Staphylococcus epidermidis. We conclude that cell wall-associated factors that promote a sessile lifestyle of S. aureus and S. epidermidis antagonize the colony spreading motility of these bacteria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22970276      PMCID: PMC3436756          DOI: 10.1371/journal.pone.0044646

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Staphylococcus aureus is an opportunistic human pathogen that is currently a leading cause of infections throughout the world. This Gram-positive bacterium can cause a wide variety of both acute and chronic diseases ranging from superficial skin infections to life-threatening endocarditis and sepsis [1], [2]. The ability of S. aureus to cause these infections is due to the production of secreted and cell wall-associated virulence factors that are coordinately expressed. These factors include proteins that are necessary for host colonization, invasion, biofilm formation, toxicogenesis, immune evasion or spreading throughout the host. To sort proteins to their correct extracytoplasmic locations, Gram-positive bacteria have several pathways for protein targeting and transport. S. aureus contains at least six of these pathways [3]. Most proteins, including virulence factors are translocated across the cytoplasmic membrane via the Sec pathway. These proteins are synthesized in the cytoplasm with an N-terminal Sec-type signal peptide that directs them to the Sec translocase, which is embedded in the membrane [3]–[7]. The Sec translocase can only facilitate the membrane passage of proteins in an unfolded state [8], [9]. Upon translocation, type I signal peptidases cleave the signal peptide to liberate the proteins from the membrane. Various folding catalysts can then assist the folding of the translocated proteins into their active and protease-resistant conformation [3], [10]–[12]. Some proteins that are translocated via the Sec pathway are retained in the membrane or cell wall. When a translocated protein lacks a specific signal for retention in these subcellular compartments, it is usually secreted into the extracellular milieu [3], [13]. Proteins can be bound to the cell wall either in a non-covalent manner via specific binding domains, or covalently through the enzymatic activity of so-called sortases. Gram-positive bacteria employ sortases to covalently link exported proteins with a special C-terminal LPxTG motif to the cell wall. These sortases are membrane-bound transpeptidases that cleave the peptide bond between the Thr and Gly residues of the LPxTG motif, and catalyze the formation of an amide bond between the carboxyl group of the Thr residue and the free amino end of a pentaglycine cross bridge in peptidoglycan precursors [14]–[19]. The sortase A (SrtA) enzyme from S. aureus is a prototypical member of the sortase family [20]–[23]. S. aureus strains lacking the srtA gene are unable to retain and display LPxTG proteins at the cell surface. As a consequence, srtA mutant strains are defective in the establishment of acute infections [21]. There are 19 staphylococcal proteins that carry a C-terminal LPxTG motif and 2 that carry a C-terminal LPxAG motif [3], [13], [24]–[26]. These include protein A (Spa), two fibronectin-binding proteins (FnbpA and FnbpB) [27], two clumping factors (ClfA and ClfB), three cell wall-anchored proteins with large serine-aspartate repeat domains (SdrC, SdrD and SdrE) [28], a collagen-binding protein (Can), a plasmin-sensitive protein (Pls) [29], FmtB [30], and eleven staphylococcal surface (Sas) proteins. For some of these proteins a direct role in biofilm formation has been reported. This applies to Spa [31], [32], FnbpA and FnbpB [33]–[36]. We have previously shown that S. aureus cells can employ secreted phenol–soluble modulins (PSMs) for their translocation over wet surfaces. At the same time, certain PSMs are very effective in preventing biofilm formation [37]. The PSMs thus seem to have a decisive role in the transitions between sessile and motile lifestyles of S. aureus. While the role of secreted PSMs in spreading motility has been established, it was so far not known whether any cell-associated factors are also involved in this process. Therefore, the primary aim of the present studies was to identify cell-associated factors that impact on spreading motility. As a first approach to find out whether any cell surface-associated proteins may be involved in spreading, we investigated spreading motility of mutant strains lacking non-essential components of the protein export and sorting machinery. Interestingly, this revealed that srtA mutant cells are more efficient spreaders than the corresponding parental strains. Further analyses showed that this relates to the spreading-limiting roles of the sortase substrates FnbpA, FnbpB, ClfA and ClfB.

Results and Discussion

The requirement for non-essential protein secretion machinery components in colony spreading by S. aureus was assessed by testing the secretion mutants listed in Table S1 for their ability to spread on TSA soft agar plates. Of all tested strains, only the srtA mutant showed a significant change in spreading. Intriguingly, this strain displayed an enhanced colony spreading phenotype as is shown in Figure 1. This spreading phenotype of the srtA mutant was completely reversed to the wild-type phenotype by ectopic expression of srtA from the plasmid srtA-pCN51 (Fig. 1).
Figure 1

Hyper-spreading phenotype of srtA mutant S. aureus strains.

From an overnight culture, an aliquot of 2 µl was spotted in the middle of a TSA plate, which was then incubated overnight at 37°C. The analyses include the laboratory strains S. aureus SH1000 and NCTC8325 (both labeled WT), as well as their srtA mutant derivatives (labeled srtA) and srtA mutants complemented with a plasmid pCN51-borne copy of S. aureus srtA (labeled srtA-pCN51). The spreading areas of the investigated mutant and parental strains were determined by ImageJ. The graphs show the areas covered in arbitrary units (AU) and respective standard deviations.

Hyper-spreading phenotype of srtA mutant S. aureus strains.

From an overnight culture, an aliquot of 2 µl was spotted in the middle of a TSA plate, which was then incubated overnight at 37°C. The analyses include the laboratory strains S. aureus SH1000 and NCTC8325 (both labeled WT), as well as their srtA mutant derivatives (labeled srtA) and srtA mutants complemented with a plasmid pCN51-borne copy of S. aureus srtA (labeled srtA-pCN51). The spreading areas of the investigated mutant and parental strains were determined by ImageJ. The graphs show the areas covered in arbitrary units (AU) and respective standard deviations. The srtA mutant strains are unable to link LPxTG proteins covalently to the cell wall and, because of this, they are attenuated in virulence. This suggested that the effect of the srtA mutation on spreading would also be an indirect consequence of the absence of cell wall coupling of one or more LPxTG proteins. Many LPxTG proteins belong to the MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) and promote bacterial attachment to the extracellular matrix of host tissues. Some of these MSCRAMMs, such as FnbpA and FnbpB, have been implicated in biofilm formation and other MSCRAMMs, such as ClfA and ClfB, have been implicated in cell-cell interactions. Since spreading motility on the one hand and biofilm formation or cell aggregation on the other hand are processes with opposite effects, we investigated whether the individual deletion of the fnbpA, fnbpB, clfA or clfB genes would result in enhanced spreading. None of these single mutant strains had a major impact on colony spreading, although the fnbpA, fnbpB and clfB mutant cells did cover slightly, but statistically significantly larger areas than the corresponding parental strain or clfA mutant cells (Fig. 2; Table S2). Since this suggested that the absence of only one of these proteins might not be sufficient for an increased spreading phenotype, double, triple and quadruple mutant strains were constructed that lacked fnbpA, fnpbB, clfA and/or clfB. As shown in Figure 2, the mutant lacking all four of these genes showed the most strongly enhanced spreading phenotype that was comparable to the phenotype of the srtA single mutant strain (for statistical evaluation, see Table S2). As shown with the double or triple mutant strains, the four individual mutations had additive effects in enhancing colony spreading. Thus, the two fibronectin-binding proteins FnbpA and FnbpB and the two clumping factors ClfA and ClfB counteract spreading. While we cannot exclude the possibility that other LPxTG proteins also counteract spreading, the observed effect of the quadruple fnbpA fnbpB clfA clfB mutation is fully sufficient to explain the hyper-spreading phenotype of the srtA mutant. It should be noted that FnbpA, FnbpB, ClfA and ClfB do not block colony spreading as evidenced by the spreading of the parental strains used in the present studies as well as a range of clinical isolates that readily spread on soft agar [38]. Thus, it seems that in the absence of FnbpA, FnbpB, ClfA and ClfB the cells are less tightly associated with each other and, consequently, they can cover larger areas on soft agar plates by means of their spreading motility.
Figure 2

The influence of fnbpA, fnbpB, clfA and clfB mutations on colony spreading of S. aureus.

Spreading motility of S. aureus SH1000-derived fnbpA, fnbpB, clfA and/or clfB mutant strains or the S. aureus Newman srtA mutant strain was assayed as described for Figure 1.

The influence of fnbpA, fnbpB, clfA and clfB mutations on colony spreading of S. aureus.

Spreading motility of S. aureus SH1000-derived fnbpA, fnbpB, clfA and/or clfB mutant strains or the S. aureus Newman srtA mutant strain was assayed as described for Figure 1. The FnbpA, FnbpB, ClfA and ClfB proteins can promote adhesion of S. aureus cells to a variety of molecules and surfaces and they have been implicated in cell-cell adhesion. In relation to our present findings, it is interesting to note that the fnpbB gene is less common in highly virulent S. aureus isolates, and that the presence of fnbpB is associated with reduced transmission of staphylococcal skin infections in a rabbit model [39], [40]. This seems to suggest that spreading activity and transmission of S. aureus could perhaps be linked. Furthermore, FnbpA is a highly variable surface protein. The fnbpA gene has a mosaic structure, which indicates that this gene is evolving not only through point mutations, but also through recombination events [41]. ClfA mediates attachment to plasma clots, to platelets and to plastic biomaterial used for medical implants. Lastly, ClfB promotes cell clumping in the presence of fibrinogen. However, ClfB is not only able to bind to fibrinogen itself, but also to proteins present in the envelope of squamous cells and to desquamated nasal epithelial cells [26], [42], [43]. Interestingly, the production of FnbpA, FnbpB, ClfA and ClfB in different S. aureus strains seems to be highly variable [38], [44], [45]. This may at least partly explain our previous observation that the spreading abilities of different S. aureus clinical isolates are highly variable [38], [44]. This view is further supported by the observation that strain Newman, which produces truncated forms of FnbpA and FnbpB, is a very efficient spreader (Fig. 2). These truncated FnbPs are no longer anchored to the cell surface but secreted, which leads to a loss of their function [46]. In fact the high spreading activity of strain Newman is comparable to that of the srtA mutant or the fnbpA fnbpB clfA clfB quadruple mutant derivative of strain SH1000 (Fig. 2). Notably, the mutations in fnbpA and fnbpB may not be sufficient to explain the increased spreading of strain Newman, but our previous studies suggest that this strain also produces very low levels of ClfB, if any [44]. This may contribute to the hyper-spreading phenotype of strain Newman. Consistent with these considerations, a srtA deletion increased the spreading capacity of strain Newman only slightly (Figure 2; Table S2). This could be due to impaired cell wall-binding of ClfA and perhaps also low-levels of ClfB. However, we cannot completely exclude the possibility that impaired cell wall-binding of other LPxTG proteins, such as Protein A, might add to the hyper-spreading phenotype of the srtA mutant of strain Newman. Depending on the strain and growth condition, the fnbpA and fnbpB genes are negatively regulated by the Agr system [47]–[49]. On the other hand, the Agr system positively regulates the synthesis of PSMs that are critical for spreading motility [38]. The differential Agr-regulated production of FnbpAB and the PSMs is thus fully compatible with our present findings that FnbpAB counteract spreading. Though the clfA and clfB genes are not regulated by Agr, but by SarA, they are highly expressed during the early exponential growth phase and barely during the late exponential or stationary growth phases [47], [50], [51]. The production of ClfA and ClfB thus correlates positively with that of FnbpAB and negatively with PSM production, which is also fully consistent with the presently observed negative role of ClfA and ClfB in spreading. Lastly, to investigate whether surface-attached proteins also set a limit to spreading motility in other staphylococci, we turned to Staphylococcus epidermidis. This bacterium is renowned for its high capacity to form biofilms on medical implants [52]. Nevertheless, S. epidermidis does produce phenol-soluble modulins [53], [54], which should provide it with an intrinsic capacity for spreading motility. As shown in Figure 3, wild-type cells of S. epidermidis strain 1457 did indeed spread on soft agar plates, albeit to a lesser extent than cells of S. aureus SH1000. As predicted on the basis of our experiments with S. aureus, the srtA mutant of S. epidermidis displayed a massively increased spreading over soft agar plates (Fig. 3). Furthermore, this hyper-spreading phenotype of the S. epidermidis srtA mutant was completely reversed to the low-level spreading of the parental strain upon ectopic expression of the S. epidermidis srtA gene from plasmid srtA-pCN51 (Fig. 3). We therefore conclude that, also in S. epidermidis, the sortase-mediated cell wall anchoring of proteins sets a limit to spreading motility. Thus, this seems to be a conserved feature of staphylococcal spreading motility, which is fully consistent with the previously shown role of covalently anchored cell wall proteins in the formation of biofilms.
Figure 3

Hyper-spreading phenotype of a srtA mutant of S. epidermidis 1457.

Spreading motility of S. epidermidis 1457 (WT), a srtA mutant derivative of this strain (srtA), and a complemented derivative of the srtA mutant (srtA-pCN51) was assayed as described for Figure 1.

Hyper-spreading phenotype of a srtA mutant of S. epidermidis 1457.

Spreading motility of S. epidermidis 1457 (WT), a srtA mutant derivative of this strain (srtA), and a complemented derivative of the srtA mutant (srtA-pCN51) was assayed as described for Figure 1.

Materials and Methods

Bacterial Strains and Growth Conditions

The bacterial strains and plasmids that were used in the present studies are listed in Table S1. All Escherichia coli strains were grown in Luria-Bertani broth (LB) at 37°C under shaking conditions. S. aureus and S. epidermidis strains were grown in tryptic soy broth (TSB) at 37°C under vigorous shaking. Where necessary, ampicillin 100 µg/ml (for E. coli) or erythromycin 5 µg/ml (for S. aureus and S. epidermidis) were added to the growth medium.

Construction of S. aureus and S. epidermidis Mutant Strains

The S. aureus and S. epidermidis mutants lacking secretion machinery genes (Table S1) were constructed using the temperature-sensitive plasmid pMAD [55] and previously described procedures [56]. All primers used are listed in Table S3. To delete particular genes, primer pairs with the designations F1/R1 and F2/R2 were used for PCR amplification of the respective upstream and downstream regions (each ∼500 bp). Primers R1 and F2 contain an overlap of 24 nucleotides, which served to fuse the amplified ‘front’ and ‘back’ flanking regions by PCR. The fused flanking regions were cloned in pMAD, and the resulting plasmids were used to delete the genes between these flanking regions from the S. aureus or S. epidermidis genome. To this end, the pMAD plasmids carrying the flanking regions were used to transform S. aureus strain RN4220 via electroporation. Next, these plasmids were isolated from the RN4220 strain and used to transform electrocompetent cells of S. aureus SH1000, NCTC8325 and Newman, or S. epidermidis 1457. Upon chromosomal plasmid insertion and excision, white colonies on plates with 80 µg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside were screened for the correct gene deletion by colony PCR using primers F1 and R2. To delete the clfA or clfB genes from the S. aureus SH1000 genome, the respective allelic replacements with antibiotic resistance markers were transferred from the original strains provided by T.J. Foster to the SH1000 strain by transduction with phage φ85 [57], [58].

Complementation of the srtA Mutation

For complementation studies, the srtA genes of S. aureus and S. epidermidis were cloned in plasmid pCN51. Expression of a cloned gene in this plasmid is controlled by a cadmium-inducible promoter. The primers used for the amplification of the srtA genes are listed in Table S3 and the restriction sites used for cloning in pCN51 are shown in italics. The resulting plasmids srtA-pCN51 and srtA-pCN51 were used to transform electrocompetent S. aureus RN4220 cells, and the transformed cells were plated on TSA plates containing erythromycin. The restriction-modified plasmids were isolated from S. aureus RN4220 and then used to transform electrocompetent S. aureus SH1000 ΔsrtA, S. aureus NCTC8325 ΔsrtA, or S. epidermidis 1457 ΔsrtA.

Colony Spreading Assay

The colony spreading assay was performed as described by Kaito et al [59], with minor modifications. Briefly, TSB broth supplemented with 0.24% agar was used to prepare TSA soft agar plates. Each plate (10 ml) was dried for approximately 10 min in a laminar flow cabinet for optimal colony spreading conditions. From a TSB overnight culture of the strain to be tested for spreading, an aliquot of 2 µl was spotted in the centre of a TSA plate and the plates were then dried for an additional 5 min. Lastly, upon overnight incubation of the plates at 37°C, the spreading zones were examined and pictures were taken. To induce srtA expression from pCN51, soft agar plates were supplemented with 0.25 µM CdSO4. All spreading assays were repeated at least five times. Bacterial strains and plasmids used in the present studies. (DOCX) Click here for additional data file. Statistical analysis of colony spreading by the different mutant strains. The spreading areas of the investigated mutant and parental strains were determined by ImageJ. The Table show the areas covered in arbitrary units (AU). P-values were determined by the non-parametric Mann–Whitney U test. (DOCX) Click here for additional data file. Primers used in the present studies. Overlapping nucleotides are shown in bold; restriction sites in primers are underlined. aThese primers have an overlap with the kanamycin resistance cassette from pDG783. (DOCX) Click here for additional data file.
  59 in total

1.  Expression of pls, a gene closely associated with the mecA gene of methicillin-resistant Staphylococcus aureus, prevents bacterial adhesion in vitro.

Authors:  K Savolainen; L Paulin; B Westerlund-Wikström; T J Foster; T K Korhonen; P Kuusela
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.

Authors:  P M Dunman; E Murphy; S Haney; D Palacios; G Tucker-Kellogg; S Wu; E L Brown; R J Zagursky; D Shlaes; S J Projan
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

3.  Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections.

Authors:  S K Mazmanian; G Liu; E R Jensen; E Lenoy; O Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif.

Authors:  H Ton-That; G Liu; S K Mazmanian; K F Faull; O Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 5.  What determines nasal carriage of Staphylococcus aureus?

Authors:  S J Peacock; I de Silva; F D Lowy
Journal:  Trends Microbiol       Date:  2001-12       Impact factor: 17.079

6.  The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target.

Authors:  M Paetzel; R E Dalbey; N C Strynadka
Journal:  Pharmacol Ther       Date:  2000-07       Impact factor: 12.310

7.  Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function.

Authors:  Matthias Grundmeier; Muzaffar Hussain; Petra Becker; Christine Heilmann; Georg Peters; Bhanu Sinha
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

8.  Identification of a fmtA-like gene that has similarity to other PBPs and beta-lactamases in Staphylococcus aureus.

Authors:  H Komatsuzawa; G H Choi; T Fujiwara; Y Huang; K Ohta; M Sugai; H Suginaka
Journal:  FEMS Microbiol Lett       Date:  2000-07-01       Impact factor: 2.742

Review 9.  Staphylococcus epidermidis biofilms: importance and implications.

Authors:  James P O'Gara; Hilary Humphreys
Journal:  J Med Microbiol       Date:  2001-07       Impact factor: 2.472

10.  Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences.

Authors:  Fiona M Roche; Ruth Massey; Sharon J Peacock; Nicholas P J Day; Livia Visai; Pietro Speziale; Alex Lam; Mark Pallen; Timothy J Foster
Journal:  Microbiology       Date:  2003-03       Impact factor: 2.777

View more
  19 in total

1.  SdrC induces staphylococcal biofilm formation through a homophilic interaction.

Authors:  E Magda Barbu; Chris Mackenzie; Timothy J Foster; Magnus Höök
Journal:  Mol Microbiol       Date:  2014-09-03       Impact factor: 3.501

2.  Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall.

Authors:  J Claes; L Liesenborghs; M Peetermans; T R Veloso; D Missiakas; O Schneewind; S Mancini; J M Entenza; M F Hoylaerts; R Heying; P Verhamme; T Vanassche
Journal:  J Thromb Haemost       Date:  2017-03-23       Impact factor: 5.824

3.  Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces.

Authors:  Eleni Tsompanidou; Emma L Denham; Dörte Becher; Anne de Jong; Girbe Buist; Marleen van Oosten; Willem L Manson; Jaap Willem Back; Jan Maarten van Dijl; Annette Dreisbach
Journal:  Appl Environ Microbiol       Date:  2012-11-26       Impact factor: 4.792

Review 4.  PSM-Mec-A Virulence Determinant that Connects Transcriptional Regulation, Virulence, and Antibiotic Resistance in Staphylococci.

Authors:  Li Qin; Joshua W McCausland; Gordon Y C Cheung; Michael Otto
Journal:  Front Microbiol       Date:  2016-08-22       Impact factor: 5.640

Review 5.  Defining motility in the Staphylococci.

Authors:  Eric J G Pollitt; Stephen P Diggle
Journal:  Cell Mol Life Sci       Date:  2017-04-04       Impact factor: 9.261

6.  Synthetic LPETG-containing peptide incorporation in the Staphylococcus aureus cell-wall in a sortase A- and growth phase-dependent manner.

Authors:  Silvie Hansenová Maňásková; Kamran Nazmi; Alex van Belkum; Floris J Bikker; Willem J B van Wamel; Enno C I Veerman
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

7.  Identification of Staphylococcus aureus colony-spreading stimulatory factors from mammalian serum.

Authors:  Yosuke Omae; Kazuhisa Sekimizu; Chikara Kaito
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

8.  Modulation of Staphylococcus aureus spreading by water.

Authors:  Mei-Hui Lin; Wan-Ju Ke; Chao-Chin Liu; Meng-Wei Yang
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

9.  Exploration of multiple Sortase A protein conformations in virtual screening.

Authors:  Chunxia Gao; Ivana Uzelac; Johan Gottfries; Leif A Eriksson
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

10.  Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe.

Authors:  Francisco Romero Pastrana; John M Thompson; Marjolein Heuker; Hedzer Hoekstra; Carly A Dillen; Roger V Ortines; Alyssa G Ashbaugh; Julie E Pickett; Matthijs D Linssen; Nicholas M Bernthal; Kevin P Francis; Girbe Buist; Marleen van Oosten; Gooitzen M van Dam; Daniel L J Thorek; Lloyd S Miller; Jan Maarten van Dijl
Journal:  Virulence       Date:  2017-12-26       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.